AI in Drug Discovery Research in China

China is a major contributor to global AI in Drug Discovery research, with 855 active researchers publishing in this field across 209 institutions in 81 cities. The country's research ecosystem in AI drug discovery combines strong institutional support, robust funding mechanisms, and collaborative research networks.

Research activity in AI in Drug Discovery across China spans fundamental investigations into machine learning to translational studies aimed at clinical applications. The distributed research community across Beijing, Shanghai, Chengdu and other cities creates diverse opportunities for researchers at all career stages.

China's research institutions have established strong programs in AI in Drug Discovery, with many achieving international recognition for their contributions to AI drug discovery research. These institutions offer:

**Research Infrastructure**: State-of-the-art facilities for machine learning research, including specialized equipment, core facilities, and technical expertise. Many institutions have made significant investments in infrastructure specifically for AI in Drug Discovery research.

**Collaborative Environment**: Strong institutional support for interdisciplinary collaboration brings together experts in AI drug discovery, machine learning, computational drug design, creating rich research environments where innovation thrives.

**Training Programs**: Comprehensive training opportunities for early-career researchers, including structured postdoctoral programs, workshops, and mentorship initiatives focused on AI drug discovery research.

**Funding Opportunities**: Access to national and international funding sources, with many institutions providing bridge funding, startup packages, and internal grants to support AI in Drug Discovery research.

The 209 institutions conducting AI in Drug Discovery research in China range from large comprehensive universities with broad biomedical programs to specialized research institutes focused on specific aspects of AI drug discovery.

Researchers interested in AI in Drug Discovery positions in China will find a range of opportunities and funding mechanisms:

**Postdoctoral Fellowships**: Many institutions offer postdoctoral positions in AI drug discovery research, often with competitive salaries and benefits. National fellowship programs may also provide funding for international researchers to conduct AI in Drug Discovery research in China.

**Research Grants**: Funding agencies in China support machine learning research through various grant mechanisms, from early-career awards to large collaborative grants. International researchers often have access to these funding opportunities.

**Industry Partnerships**: Growing interest from biotechnology and pharmaceutical companies has created partnerships with academic institutions, providing additional research funding and career opportunities in computational drug design.

**Career Development**: Many institutions in China provide structured career development support for researchers, including grant writing assistance, mentorship programs, and professional development workshops.

Explore the cities and institutions below to discover specific opportunities in AI in Drug Discovery research across China.